PLAY PODCASTS
Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments

Mission Matters Innovation with Adam Torres

January 30, 202518m 45s

Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma.


Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule.


Apply to be a guest on our podcast:

https://missionmatters.lpages.co/podcastguest/


Visit our website:

https://missionmatters.com/


More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia

Learn more about your ad choices. Visit podcastchoices.com/adchoices